Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Augusta
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Augusta, GA

Studies commonly pay $75 to $4,500 per completed study

185 clinical trials are currently recruiting participants within 30 miles of Augusta. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

185studies recruiting
5+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Augusta right now

Top 25 of 185 recruiting studies, sorted by proximity — each links to its official registry page

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought
Clinical Trial Site — Augusta, Georgia (9.2 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04202341)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
Local Institution - 0412 — Augusta, Georgia (9.2 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361510)

Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease Phase 1, Phase 2 Interventional 100 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Atavistik Bio, Inc
See eligibility & contact on ClinicalTrials.gov (NCT07601425)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 2 Interventional 60 participants sought
Investigator Site #29 — Augusta, Georgia (9.2 mi) · Sponsor: Akebia Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07268638)

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Diabetic Retinopathy Phase 2, Phase 3 Interventional 576 participants sought
Southeast Retina Center /ID# 274739 — Augusta, Georgia (9.2 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07592273)

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Candidemia, Candidiasis, Invasive Phase 3 Interventional 450 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Basilea Pharmaceutica
See eligibility & contact on ClinicalTrials.gov (NCT05421858)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Age-related Wet Macular Degeneration Phase 1 Interventional 45 participants sought
CBCC Global Research Site:001 — Augusta, Georgia (9.2 mi) · Sponsor: Caregen Co. Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06132035)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought
Augusta Oncology Associates PC-D'Antignac — Augusta, Georgia (9.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04871542)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Augusta Oncology Associates PC-D'Antignac — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Parkinson Disease Phase 2 Interventional 150 participants sought
Augusta University Medical Center (Site #212) — Augusta, Georgia (9.2 mi) · Sponsor: Appello Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07432958)

DALY II USA/ MB-CART2019.1 for DLBCL

Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma Phase 2 Interventional 315 participants sought
Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Miltenyi Biomedicine GmbH
See eligibility & contact on ClinicalTrials.gov (NCT04792489)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer Phase 3 Interventional 770 participants sought
Augusta University - Georgia Cancer Center ( Site 0066) — Augusta, Georgia (9.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06824467)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT03150693)

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Normal Subjects, Fecal Incontinence N/A Interventional 155 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: The California Medical Innovations Institute, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05412069)

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Multiple Myeloma, Autologous Stem Cell Transplantation Phase 3 Interventional 172 participants sought
Wellstar MCG — Augusta, Georgia (9.2 mi) · Sponsor: Augusta University
See eligibility & contact on ClinicalTrials.gov (NCT06588413)

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Acute Myeloid Leukaemia (AML) Phase 2, Phase 3 Interventional 312 participants sought
Augusta University - Georgia Cancer Center — Augusta, Georgia (9.2 mi) · Sponsor: Moleculin Biotech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06788756)
Actively enrolling

Studies you may be able to join near Augusta

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Augusta

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Southeastern Clinical Research Institute

1521 Anthony Rd, Augusta, GA 30904
(706) 922-3005

Masters of Clinical Research

1232 Augusta W Pkwy, Augusta, GA 30909
(706) 210-8890

Telemedicine & Advanced Technology Research Center (TATRC) Digital Health Innovation Center (DHIC)

300 E Hospital Rd, Fort Gordon, GA 30905
(301) 619-7927

Georgia Prevention Institute

★ 4.8
1499 Walton Wy, Augusta, GA 30912
(706) 721-4534
"A place for and of exercise and health that lives up to the standard of pushing yourself. I am still sore."
— Richard Drake, 4★

Georgia Cancer Center - M. Bert Storey Research Building

★ 5.0
1410 Laney Walker Blvd, Augusta, GA 30912
(706) 721-0570
"Such professional caring care throughout all stages of care - from physicians to auxiliary medical care to clinic and infusion nurses to medical assi…"
— Genie Fulcher, 5★

Clinical trials in Augusta: what's recruiting

The Augusta area currently has 185 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Augusta, the most active research areas are:

  • Cancer & Oncology10 studies
  • Diabetes & Metabolism2 studies
  • Brain & Mental Health1 studies
  • Immune & Skin1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Augusta, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Augusta

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Augusta participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How do I join a study in Augusta, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Augusta?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Augusta?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Augusta.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Augusta typically complete one or two studies per year.

Paid clinical trials near Augusta

Other metros within reach

Columbia, SC190 Athens, GA75 Mauldin, SC378 Greenville, SC380 Spartanburg, SC364 Savannah, GA176 Macon, GA73 Warner Robins, GA73

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Augusta Chronic Kidney Disease (HealthMatch) in Augusta Bladder Issues Due To Spinal Cord Injury in Augusta All conditions

More of GA

Atlanta1,722 Savannah176 Gainesville149 Athens75 Macon73 Warner Robins73 Columbus71

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts